Weill Cornell Medicine researchers have demonstrated, for the first time, that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.”
A new preclinical study from Weill Cornell Medicine found that a protein long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin does.
Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief.
Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein; the discovery could lead to new therapies for blood coagulation disorders, cancers and other conditions.
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.
As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children.
A new study helps resolve a long-standing paradox in biology about genome architecture and cell function, which may provide insights into certain developmental disorders and cancers.
